Merrimack Pharmaceuticals Inc. Secures $60,000,000 Series F Funding

  • Feed Type
  • Date
    6/10/2008
  • Company Name
    Merrimack Pharmaceuticals Inc.
  • Mailing Address
    One Kendall Square, Building 700, 2nd Fl Cambridge, MA 02139
  • Company Description
    Merrimack Pharmaceuticals, Inc. is a privately held biotechnology company based in Cambridge, Massachusetts. We are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer.
  • Website
    http://www.merrimackpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $60,000,000
  • Transaction Round
    Series F
  • Proceeds Purposes
    Proceeds from the financing will be used to advance Merrimack’s proprietary pipeline of biologic therapiestargeting autoimmune disease and cancer.
  • M&A Terms
  • Venture Investor
    Credit Suisse
  • Venture Investor
    Crocker Capital
  • Venture Investor
    Undisclosed